Try our Advanced Search for more refined results
MOLNAR et al v. MERCK & CO., INC.
Case Number:
3:08-cv-00008
Court:
Nature of Suit:
Judge:
Firms
- Alonso Krangle
- Anapol Weiss
- Beasley Firm
- Blank Rome
- Bowman & Brooke
- Carella Byrne
- Cervantes & Associates
- Cohn Lifland
- Douglas & London
- Dughi Hewit
- Eckert Seamans
- Environmental Litigation Group PC
- Flaster Greenberg
- Fox Rothschild
- Gallagher Law
- Goldberg Segalla
- Goodwin Procter
- Goss Law Firm PC
- Goza & Honnold
- Greenberg Traurig
- Greenspoon Marder
- Gurfein Douglas
- Hardin Kundla
- Harris Beach PLLC
- Hawkins Parnell
- Hughes Hubbard
- Javerbaum Wurgaft
- K&L Gates
- Levin Sedran
- Lewis Brisbois
- Lieff Cabraser
- Lowenstein Sandler
- Lynch Daskal
- McSweeney Langevin
- Milberg Coleman
- Motley Rice
- Parker Waichman
- Porzio Bromberg
- Rawle & Henderson
- Raynes & Lawn
- Reed Smith
- Rheingold Giuffra
- Rosenbaum & Rosenbaum
- Ross Feller Casey
- Seeger Weiss
- Sills Cummis
- Swensen & Perer
- Taczak Law Office
- VSCP Law
- Weitz & Luxenberg
Companies
- Apotex Inc.
- Dr. Reddy's Laboratories Ltd.
- Genentech Inc.
- IRIS International, Inc.
- McKesson Corp.
- Merck & Co. Inc.
- Mylan NV
- Sanofi
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Warner Chilcott Limited
Government Agencies
Sectors & Industries:
-
March 23, 2022
Merck Wins Preemption Ruling In Fosamax Warning MDL
A New Jersey federal judge ruled Wednesday that the U.S. Food and Drug Administration's rejection of a proposed warning from Merck means federal law preempts state law claims in multidistrict litigation that the company failed to warn consumers about certain fracture risks of its osteoporosis drug Fosamax.
-
September 05, 2014
Merck Ordered Into Mediation In Fosamax Litigation
A New Jersey federal judge has ordered Merck & Co. Inc. and plaintiffs in multidistrict litigation accusing the company of negligence over femur fractures allegedly caused by its osteoporosis drug Fosamax to mediate, saying that after several years of litigation it is now an appropriate time to do so.
-
June 17, 2014
Merck Defeats Bellwether Case In Fosamax Femur-Injury MDL
A New Jersey federal judge on Tuesday dismissed a suit brought against Merck & Co. Inc. in multidistrict litigation accusing the company of negligence over femur fractures allegedly caused by its osteoporosis drug Fosamax, finding the failure to warn claims fail because the drug's label is clear and accurate.
-
March 26, 2014
Merck Escapes Some Injury Claims In Fosamax MDL
A New Jersey federal judge on Wednesday tossed some claims brought against Merck & Co. Inc. in multidistrict litigation accusing the company of negligence over femur fractures and similar injuries allegedly caused by its osteoporosis drug Fosamax, saying those claims are preempted.
-
June 27, 2013
Merck Off The Hook In Fosamax Fracture Suit, Judge Rules
A New Jersey federal judge on Thursday said claims that Merck & Co. failed to warn a consumer of the possible risk of femur fractures from the use of its bone drug Fosamax are preempted under federal law because the U.S. Food and Drug Administration refused to strengthen the drug's label the year the consumer was injured.